Skip to main content
. 2018 May 14;8(5):e022899. doi: 10.1136/bmjopen-2018-022899

Table 3.

Exercise prescription for cycle 0 (weeks 1–4), a fully supervised introduction to exercise while incrementally building exercise capacity

Period Resistance exercise Aerobic exercise
Cycle 0 (week 1)
 Session 1 1 set × 8RM × 6 exercises 3×30 s at RPE (5), with 90 s recovery
 Session 2 10 min at RPE (4) (with 2 min recovery as needed)
 Session 3 1 set × 12RM × 6 exercises 3 × 30 s at RPE (5), with 90 s recovery
Cycle 0 (week 2)
 Session 1 2 sets × 8RM × 6 exercises 4 × 30 s at RPE (6), with 90 s recovery
 Session 2 10 min at RPE (4) (with 2 min recovery as needed)
 Session 3 2 sets × 120RM × 6 exercises 4 × 30 s at RPE (6), with 90 s recovery
Cycle 0 (week 3)
 Session 1 3 sets × 8RM × 6 exercises 3 × 60 s at RPE (6), with 120 s recovery
 Session 2 15 min at RPE (5) (with 2 min recovery as needed)
 Session 3 3 sets × 12RM × 6 exercises 3 × 60 s at RPE (6), with 120 s recovery
Cycle 0 (week 4–de-load)
 Session 1 2 sets × 8RM × 6 exercises 3 × 30 s at RPE (6), with 90 s recovery
 Session 2 10 min at RPE (4) (with 2 min recovery as needed)
 Session 3 2 sets × 12RM × 6 exercises 3 × 30 s at RPE (6), with 90 s recovery
Additional descriptions
 INTERVAL-GAP4 prescription provides a gradually incremental introduction to the exercise programme across cycle 0 (weeks 1–4). This familiarises and prepares patients for their subsequent participation in moderate-to-high load resistance exercise, as well as high-intensity interval and moderate-intensity continuous aerobic exercise. This cycle also contains a de-load week to increase recovery and promote adaptation prior to progressing into the full prescription. Programme intensity is provided through a repetition maximum (RM) and rating of perceived exertion (RPE) system to support exercise autoregulation and patient management throughout cancer treatment and disease progression as needed.11